Sciatica Treatment Market: Current Analysis and Forecast (2023-2030)

$3999$6999

Emphasis on Disease Type (Acute Sciatica, Chronic Sciatica, Others); Drug Class (Non-steroidal anti-inflammatory drugs (NSAIDs), Steroids, Antidepressants, Others (muscle relaxants, analgesics, opioids); End User (Hospital Pharmacies, Retail and Specialty Pharmacies, Online Providers); Region/Country

Pages:

173

Table:

82

Figure:

106

Report ID:

UMHE212295

Geography:

Clear
  Get a Sample
Report Description
Table of content
Research Methodology

Report Description

Sciatica Treatment Market
Sciatica Treatment Market

The sciatica treatment market is expected to grow at a strong CAGR of around 8.2% during the forecast period owing to the surge in the incidence of diseases like spine tumors and herniated discs, rising research and development activities for enhancing pain relief and aiding in sciatica treatment, and rising geriatric population globally. For instance, according to the report of the United States Census Bureau in 2021, more than 54 million people of geriatric age were living in the country in 2020 and this number is expected to reach 85.7 million by 2050, which will be about 20% of the total population of the U.S. In addition to this, the increasing clinical trials by pharmaceutical companies to find a cure for sciatic nerve pain is also driving the sciatica treatment market. Global pharmaceutical giants are leaving no stone unturned to showcase their potential. For instance, a subsidiary of SpineThera, Inc., SpineThera Australia performed a phase I/II clinical trial study to find the safety and efficacy of two doses of SX600 administered by lumbosacral transforaminal epidural injection in patients with lumbar intervertebral disc herniation in 2022.

Some of the major players operating in the market include Alkem Labs; Amneal Pharmaceuticals LLC.; Johnson & Johnson Services, Inc.; Sinfonia Biotherapeutics; Vita Life Sciences; Abbott; Aurobindo Pharma; Sorrento Therapeutics, Inc.; Sun Pharmaceutical Industries Ltd.; Teva Pharmaceutical Industries Ltd.

Insights Presented in the Report

“Amongst disease type, the chronic sciatica category to grow with high CAGR during the forecast period”

Based on disease type, the market is segmented into acute sciatica, chronic sciatica, and others. The chronic sciatica segment is expected to hold a significant share in the forecast period owing to the increased tendency of the current generation for prolonged sitting in professional environments which leads to increased stress on spinal discs and causes back pain. According to reports from the U.S Centers for Disease Control and Prevention in July 2021, 39% of adults experienced back pain, 36.5% of them experienced lower limb pain, and 30.7% of them experienced upper limb pain due to bad lifestyle habits. Thus, amongst disease types, the chronic sciatica category is expected to grow with a high CAGR during the forecast period.

“Amongst drug class, the non-steroidal anti-inflammatory drug (NSAIDs) segment to grow with a significant rate in forecast period”

By drug class, the market is categorized into non-steroidal anti-inflammatory drugs (NSAIDs), steroids, antidepressants, and others (muscle relaxants, analgesics, opioids). The non-steroidal anti-inflammatory drug (NSAIDs) segment is anticipated to grow with significant CAGR during the forecast period majorly due to the easy availability and low cost, frequent prescription by the doctors of NSAIDs. Also, newer launches by pharmaceutical companies of a better version of NSAIDs are driving this segment. For instance, in November 2022, U.S-based Camber Pharmaceuticals introduced an NSAID, Naproxen oral suspension to a growing lineup of generic products which is designed to reduce pain, swelling, and stiffness in joints. Thus, amongst the drug class, the non-steroidal anti-inflammatory drug (NSAIDs) segment is expected to grow at a significant rate in the forecast period.

“Amongst end users, the online provider segment to grow with a significant rate in forecast period”

Based on end users, the market is segmented into hospital pharmacies, retail and specialty pharmacies, and online providers. The online providers are expected to grow with high CAGR owing to the time-saving process of obtaining medications. Also, online providers offer heavy discounts on medicines which attract consumers. For instance, Forbes Health rated the best online pharmacies of September 2023 and included Express Scripts Pharmacy, Amazon Pharmacy, Birdi, BlinkRx, HealthWarehouse, CaryRx, and Rx Outreach in the list under categories like best for member benefits, best for fast delivery, best for accessible customer service and more. Thus, amongst end users, the online provider segment is expected to grow at a significant rate in the forecast period.

Sciatica Treatment Market Report Coverage

Sciatica Treatment Market
Sciatica Treatment Market

“APAC to grow with high CAGR during the forecast period”

APAC is expected to grow with the highest CAGR during the forecast period. Several factors, such as the rising prevalence of spinal diseases, a large patient pool, a rising geriatric population, and rising research and development activities are driving the regional market growth. Countries such as India and China offer attractive investment opportunities for clinical research and are anticipated to positively drive research and development prospects for sciatica treatment. In addition to this, rising obesity among adults is a major driving factor for this segment. For instance, the World Health Organization in 2021 estimated that in Southeast Asia 6.6 million young children under 5 years and one in five adults are currently overweight, which is expected to significantly rise in upcoming years.  Hence, given the large population size of APAC, it is expected to grow with a high CAGR during the forecast period.

Reasons to buy this report:

  • The study includes market sizing and forecasting analysis validated by authenticated key industry experts.
  • The report presents a quick review of overall industry performance at one glance.
  • The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolios, expansion strategies, and recent developments.
  • Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry.
  • The study comprehensively covers the market across different segments.
  • Deep dive regional level analysis of the industry.

Customization Options:

The global sciatica treatment market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

You can also purchase parts of this report. Do you want to check out a section wise
price list?

1.1.Market Definitions
1.2.Main Objective
1.3.Stakeholders
1.4.Limitation
2.1.Research Process of the Sciatica Treatment Market
2.2.Research Methodology of the Sciatica Treatment Market
2.3.Respondent Profile
3MARKET SYNOPSIS
4EXECUTIVE SUMMARY
5IMPACT OF COVID-19 ON THE SCIATICA TREATMENT MARKET
6SCIATICA TREATMENT MARKET REVENUE (USD BN), 2020-2030F
 7.1.Acute Sciatica
 7.2.Chronic Sciatica
 7.3.Others 
 8.1.Non-steroidal anti-inflammatory drugs (NSAIDs)
 8.2.Steroids   
 8.3.Antidepressants 
 8.4.Others (muscle relaxants, analgesics, opioids)
9.1.Hospital Pharmacies 
9.2.Retail and Specialty Pharmacies
9.3.Online Providers 
10.1.North America   
 10.1.1.U.S. 
 10.1.2.Canada 
 10.1.3.Rest of North America
10.2.Europe   
 10.2.1.Germany 
 10.2.2.U.K. 
 10.2.3.France 
 10.2.4.Italy 
 10.2.5.Spain 
 10.2.6.Rest of Europe
10.3.Asia-Pacific  
 10.3.1.China 
 10.3.2.Japan 
 10.3.3.India 
 10.3.4.Rest of Asia-Pacific
10.4.Rest of World  
11.1.Market Drivers
11.2.Market Challenges
12SCIATICA TREATMENT MARKET OPPORTUNITIES
13SCIATICA TREATMENT MARKET TRENDS
14.1.Demand Side Analysis
14.2.Supply Side Analysis
15VALUE CHAIN ANALYSIS
16.1.Competitive Landscape 
 16.1.1.Porters Fiver Forces Analysis
17.1.Alkem Labs 
17.2.Amneal Pharmaceuticals LLC.
17.3.Johnson & Johnson Services, Inc. 
17.4.Sinfonia Biotherapeutics
17.5.Vita Life Sciences 
17.6.Abbott  
17.7.Aurobindo Pharma 
17.8.Sorrento Therapeutics, Inc.
17.9.Sun Pharmaceutical Industries Ltd.
17.10.Teva Pharmaceutical Industries Ltd.

 

18DISCLAIMER

Research Methodology

Research Methodology for the Sciatica Treatment Market Analysis (2023-2030)

Analyzing the historical market, estimating the current market, and forecasting the future market of the global sciatica treatment market were the three major steps undertaken to create and analyze the adoption of sciatica treatment in major regions globally. Exhaustive secondary research was conducted to collect the historical market numbers and estimate the current market size. Secondly, to validate these insights, numerous findings and assumptions were taken into consideration. Moreover, exhaustive primary interviews were also conducted, with industry experts across the value chain of the global sciatica treatment market. Post assumption and validation of market numbers through primary interviews, we employed a top-down/bottom-up approach to forecasting the complete market size. Thereafter, market breakdown and data triangulation methods were adopted to estimate and analyze the market size of segments and sub-segments of the industry pertains to. Detailed methodology is explained below:

Analysis of Historical Market Size

Step 1: In-Depth Study of Secondary Sources:

Detail secondary study was conducted to obtain the historical market size of the sciatica treatment market through company internal sources such as annual reports & financial statements, performance presentations, press releases, etc., and external sources including journals, news & articles, government publications, competitor publications, sector reports, third-party database, and other credible publications.

Step 2: Market Segmentation:

After obtaining the historical market size of the sciatica treatment market, we conducted a detailed secondary analysis to gather historical market insights and share for different segments and sub-segments for major regions. Major segments are included in the report as disease type, drug class, end user, and regions. Further country-level analyses were conducted to evaluate the overall adoption of testing models in that region.

Step 3: Factor Analysis:

After acquiring the historical market size of different segments and sub-segments, we conducted a detailed factor analysis to estimate the current market size of the sciatica treatment market. Further, we conducted factor analysis using dependent and independent variables such as disease type, drug class, end user, and regions of the sciatica treatment market. A thorough analysis was conducted for demand and supply-side scenarios considering top partnerships, mergers and acquisitions, business expansion, and product launches in the sciatica treatment market sector across the globe.

Current Market Size Estimate & Forecast

Current Market Sizing: Based on actionable insights from the above 3 steps, we arrived at the current market size, key players in the global sciatica treatment market, and market shares of the segments. All the required percentage shares split, and market breakdowns were determined using the above-mentioned secondary approach and were verified through primary interviews.

Estimation & Forecasting: For market estimation and forecast, weights were assigned to different factors including drivers & trends, restraints, and opportunities available for the stakeholders. After analyzing these factors, relevant forecasting techniques i.e., the top-down/bottom-up approach were applied to arrive at the market forecast for 2030 for different segments and sub-segments across the major markets globally. The research methodology adopted to estimate the market size encompasses:

  • The industry’s market size, in terms of revenue (USD) and the adoption rate of the sciatica treatment market across the major markets domestically
  • All percentage shares, splits, and breakdowns of market segments and sub-segments
  • Key players in the global sciatica treatment market in terms of products offered. Also, the growth strategies adopted by these players to compete in the fast-growing market

Market Size and Share Validation

Primary Research: In-depth interviews were conducted with the Key Opinion Leaders (KOLs) including Top Level Executives (CXO/VPs, Sales Head, Marketing Head, Operational Head, Regional Head, Country Head, etc.) across major regions. Primary research findings were then summarized, and statistical analysis was performed to prove the stated hypothesis. Inputs from primary research were consolidated with secondary findings, hence turning information into actionable insights.

Split of Primary Participants in Different Regions

Sciatica Treatment Market Report Coverage
Sciatica Treatment Market Report Coverage

Market Engineering

The data triangulation technique was employed to complete the overall market estimation and to arrive at precise statistical numbers for each segment and sub-segment of the global sciatica treatment market. data was split into several segments & sub-segments post studying various parameters and trends in the areas of the disease type, drug class, end user, and regions in the global sciatica treatment market.

The main objective of the Global Sciatica Treatment Market Study

The current & future market trends of the global sciatica treatment market were pinpointed in the study. Investors can gain strategic insights to base their discretion for investments on the qualitative and quantitative analysis performed in the study. Current and future market trends determined the overall attractiveness of the market at a regional level, providing a platform for the industrial participant to exploit the untapped market to benefit from a first-mover advantage. Other quantitative goals of the studies include:

  • Analyze the current and forecast market size of the sciatica treatment market in terms of value (USD). Also, analyze the current and forecast market size of different segments and sub-segments
  • Segments in the study include areas of the disease type, drug class, end user, and regions Define and analyze the regulatory framework for the sciatica treatment industry
  • Analyze the value chain involved with the presence of various intermediaries, along with analyzing customer and competitor behaviors of the industry
  • Analyze the current and forecast market size of the sciatica treatment market for the major region
  • Major countries of regions studied in the report include Asia Pacific, Europe, North America, and the Rest of the World
  • Company profiles of the sciatica treatment market and the growth strategies adopted by the market players to sustain in the fast-growing market
  • Deep dive regional level analysis of the industry

You can also purchase parts of this report. Do you want to check out a section wise
price list?